In May of 2020, a viral disease called Monkeypox, named after an earlier presumed source of the disease,

as folks who had contact with wild mammals of various kinds, including ostensibly at least at times

monkeys, were the most likely to be afflicted by it.

Monkeypox was detected in some unusual places, including the United Kingdom, which is where

a case that popped up on the medical

community's radar on May 6, triggered a scan of medical records to see if any more cases

might have been recorded, but not necessarily noticed for what they were because of how unusual

this disease is beyond a few African regions. That more focused search found another

four cases which, alarmingly, seemed to be the consequence of communal spread, meaning they

stemmed from person-to-person contact rather than being the result of exposure to an infected

wild animal, which is not something we've seen on any

scale before, and that, in turn, led to even more focused tracking efforts that found another

several dozen cases around Europe. As of the day I'm recording this in mid-October of 2022,

there have been 68,488 confirmed cases in 108 different countries, about 9,440 suspected,

but unconfirmed cases, and somewhere around a dozen deaths outside regions where the disease is

endemic. So there have been something like 120 deaths in endemic regions,

and less than a tenth of that, in regions outside those relatively poor and health care scarce areas.

Part of why there's such a large outcome disparity, especially in terms of deaths caused by monkeypox,

between these regions

is that some areas are able to provide treatment and convince or coerce people

into limiting contact with other people until their symptoms have passed.

And the detection and labeling of those symptoms is a big part of this effort,

...